Am. J. Respir. Cell Mol. Biol., Vol 16, No. 5, 05 1997, 557-567.
Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung
WM Maniscalco, RH Watkins, CT D'Angio and RM Ryan
Department of Pediatrics, Strong Children's Research Center, University of Rochester School of Medicine, New York 14642, USA.
Normal neonatal lung growth requires a substantial increase in
microvascular endothelial cells. Oxygen injury to neonatal lung destroys
endothelial cells and alters the normal process of alveolarization,
including development of the microvasculature. The mechanisms that regulate
lung alveolar capillary growth and development are not known. Vascular
endothelial growth factor (VEGF) is a specific mitogen for endothelial
cells that is often expressed by epithelial cells in close proximity to
capillary beds. VEGF expression is induced by hypoxia and may be inhibited
by hyperoxia. We examined the cell- specific expression of VEGF during
normal postnatal lung development and the effects of hyperoxic lung injury
on VEGF mRNA and protein in vivo. Normal newborn rabbits between 1 day and
5 wk of age had VEGF transcripts located mainly in alveolar epithelial
cells, with little or no VEGF mRNA noted in smooth muscle or endothelial
cells. A subpopulation of freshly isolated, normal type II cells, but not
mesenchymal cells, expressed VEGF mRNA. Newborn rabbits exposed to 100%
oxygen for 4 days had no change in VEGF mRNA abundance, transcript
location, or immunostaining. Animals exposed to 100% oxygen for an average
of 9 days had an 80% decrease in lung VEGF mRNA abundance, decreased
alveolar epithelial cell VEGF expression, and decreased VEGF
immunostaining. Recovery of VEGF expression to control levels occurred
during a 5-day recovery period. We conclude that alveolar epithelial cells
in postnatal lung express VEGF, suggesting epithelial regulation of
alveolar capillary formation. Furthermore, hyperoxic injury decreases
neonatal lung VEGF mRNA and protein, which may be a contributory mechanism
of impaired postnatal microvascular development in oxygen injury.
This article has been cited by other articles:

|
 |

|
 |
 
D. E. Simcock, V. Kanabar, G. W. Clarke, K. Mahn, C. Karner, B. J. O'Connor, T. H. Lee, and S. J. Hirst
Induction of Angiogenesis by Airway Smooth Muscle From Patients with Asthma
Am. J. Respir. Crit. Care Med.,
September 1, 2008;
178(5):
460 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Abman
The Dysmorphic Pulmonary Circulation in Bronchopulmonary Dysplasia: A Growing Story
Am. J. Respir. Crit. Care Med.,
July 15, 2008;
178(2):
114 - 115.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Buckley, W. Shi, L. Barsky, and D. Warburton
TGF-{beta} signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury
Am J Physiol Lung Cell Mol Physiol,
April 1, 2008;
294(4):
L739 - L748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Xu, R. E. Perez, I. I. Ekekezie, A. Navarro, and W. E. Truog
Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death
Am J Physiol Lung Cell Mol Physiol,
January 1, 2008;
294(1):
L17 - L23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gien, G. J. Seedorf, V. Balasubramaniam, N. Markham, and S. H. Abman
Intrauterine Pulmonary Hypertension Impairs Angiogenesis In Vitro: Role of Vascular Endothelial Growth Factor Nitric Oxide Signaling
Am. J. Respir. Crit. Care Med.,
December 1, 2007;
176(11):
1146 - 1153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-R. Tang, G. Seedorf, V. Balasubramaniam, A. Maxey, N. Markham, and S. H. Abman
Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition
Am J Physiol Lung Cell Mol Physiol,
November 1, 2007;
293(5):
L1271 - L1280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Simcock, V. Kanabar, G. W. Clarke, B. J. O'Connor, T. H. Lee, and S. J. Hirst
Proangiogenic Activity in Bronchoalveolar Lavage Fluid from Patients with Asthma
Am. J. Respir. Crit. Care Med.,
July 15, 2007;
176(2):
146 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nakanishi, T. Sugiura, J. B. Streisand, S. M. Lonning, and J. D. Roberts Jr
TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung
Am J Physiol Lung Cell Mol Physiol,
July 1, 2007;
293(1):
L151 - L161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thebaud and S. H. Abman
Bronchopulmonary Dysplasia: Where Have All the Vessels Gone? Roles of Angiogenic Growth Factors in Chronic Lung Disease
Am. J. Respir. Crit. Care Med.,
May 15, 2007;
175(10):
978 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Siner, G. Jiang, Z. I. Cohen, P. Shan, X. Zhang, C. G. Lee, J. A. Elias, and P. J. Lee
VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo
FASEB J,
May 1, 2007;
21(7):
1422 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kanazawa, S. Nomura, and K. Asai
Roles of Angiopoietin-1 and Angiopoietin-2 on Airway Microvascular Permeability in Asthmatic Patients
Chest,
April 1, 2007;
131(4):
1035 - 1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Kunig, V. Balasubramaniam, N. E. Markham, G. Seedorf, J. Gien, and S. H. Abman
Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia
Am J Physiol Lung Cell Mol Physiol,
November 1, 2006;
291(5):
L1068 - L1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A R L Medford and A B Millar
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
Thorax,
July 1, 2006;
61(7):
621 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Lopez, O. Boucherat, M.-L. Franco-Montoya, J. R. Bourbon, C. Delacourt, and P.-H. Jarreau
Nitric Oxide Donor Restores Lung Growth Factor and Receptor Expression in Hyperoxia-Exposed Rat Pups
Am. J. Respir. Cell Mol. Biol.,
June 1, 2006;
34(6):
738 - 745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol,
February 1, 2006;
290(2):
L209 - L221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev,
January 1, 2006;
86(1):
279 - 367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Auten, M. A. O'Reilly, T. D. Oury, E. Nozik-Grayck, and M. H. Whorton
Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia
Am J Physiol Lung Cell Mol Physiol,
January 1, 2006;
290(1):
L32 - L40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Stenmark and V. Balasubramaniam
Angiogenic Therapy for Bronchopulmonary Dysplasia: Rationale and Promise
Circulation,
October 18, 2005;
112(16):
2383 - 2385.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thebaud, F. Ladha, E. D. Michelakis, M. Sawicka, G. Thurston, F. Eaton, K. Hashimoto, G. Harry, A. Haromy, G. Korbutt, et al.
Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury: Evidence That Angiogenesis Participates in Alveolarization
Circulation,
October 18, 2005;
112(16):
2477 - 2486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Kunig, V. Balasubramaniam, N. E. Markham, D. Morgan, G. Montgomery, T. R. Grover, and S. H. Abman
Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats
Am J Physiol Lung Cell Mol Physiol,
October 1, 2005;
289(4):
L529 - L535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ladha, S. Bonnet, F. Eaton, K. Hashimoto, G. Korbutt, and B. Thebaud
Sildenafil Improves Alveolar Growth and Pulmonary Hypertension in Hyperoxia-induced Lung Injury
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
750 - 756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. McGrath-Morrow, C. Cho, C. Cho, L. Zhen, D. J. Hicklin, and R. M. Tuder
Vascular Endothelial Growth Factor Receptor 2 Blockade Disrupts Postnatal Lung Development
Am. J. Respir. Cell Mol. Biol.,
May 1, 2005;
32(5):
420 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-R. Tang, N. E. Markham, Y.-J. Lin, I. F. McMurtry, A. Maxey, J. P. Kinsella, and S. H. Abman
Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor
Am J Physiol Lung Cell Mol Physiol,
August 1, 2004;
287(2):
L344 - L351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Hosford and D. M. Olson
Effects of hyperoxia on VEGF, its receptors, and HIF-2{alpha} in the newborn rat lung
Am J Physiol Lung Cell Mol Physiol,
July 1, 2003;
285(1):
L161 - L168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koyama, E. Sato, A. Tsukadaira, M. Haniuda, H. Numanami, M. Kurai, S. Nagai, and T. Izumi
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro
Eur. Respir. J.,
December 1, 2002;
20(6):
1449 - 1456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Maniscalco, R. H. Watkins, M. A. O'Reilly, and C. P. Shea
Increased epithelial cell proliferation in very premature baboons with chronic lung disease
Am J Physiol Lung Cell Mol Physiol,
November 1, 2002;
283(5):
L991 - L1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Pham, T. Uchida, C. Planes, L. B. Ware, R. Kaner, M. A. Matthay, and C. Clerici
Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo
Am J Physiol Lung Cell Mol Physiol,
November 1, 2002;
283(5):
L1133 - L1142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Kanazawa, K Hirata, and J Yoshikawa
Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients
Thorax,
October 1, 2002;
57(10):
885 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lassus, I. Nupponen, A. Kari, M. Pohjavuori, and S. Andersson
Early Postnatal Dexamethasone Decreases Hepatocyte Growth Factor in Tracheal Aspirate Fluid From Premature Infants
Pediatrics,
October 1, 2002;
110(4):
768 - 771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Le Cras, N. E. Markham, R. M. Tuder, N. F. Voelkel, and S. H. Abman
Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure
Am J Physiol Lung Cell Mol Physiol,
September 1, 2002;
283(3):
L555 - L562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Ozaki, K. D. Beharry, K. C. Nishihara, Y. Akmal, J. G. Ang, R. Sheikh, and H. D. Modanlou
Regulation of Retinal Vascular Endothelial Growth Factor and Receptors in Rabbits Exposed to Hyperoxia
Invest. Ophthalmol. Vis. Sci.,
May 1, 2002;
43(5):
1546 - 1557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. BHATT, G. S. PRYHUBER, H. HUYCK, R. H. WATKINS, L. A. METLAY, and W. M. MANISCALCO
Disrupted Pulmonary Vasculature and Decreased Vascular Endothelial Growth Factor, Flt-1, and TIE-2 in Human Infants Dying with Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med.,
November 15, 2001;
164(10):
1971 - 1980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. LASSUS, M. TURANLAHTI, P. HEIKKILA, L. C. ANDERSSON, I. NUPPONEN, A. SARNESTO, and S. ANDERSSON
Pulmonary Vascular Endothelial Growth Factor and Flt-1 in Fetuses, in Acute and Chronic Lung Disease, and in Persistent Pulmonary Hypertension of the Newborn
Am. J. Respir. Crit. Care Med.,
November 15, 2001;
164(10):
1981 - 1987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. THICKETT, L. ARMSTRONG, S. J. CHRISTIE, and A. B. MILLAR
Vascular Endothelial Growth Factor May Contribute to Increased Vascular Permeability in Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med.,
November 1, 2001;
164(9):
1601 - 1605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Allen, B. K. Schneider, and C. W. White
Limitations to oxygen diffusion and equilibration in in vitro cell exposure systems in hyperoxia and hypoxia
Am J Physiol Lung Cell Mol Physiol,
October 1, 2001;
281(4):
L1021 - L1027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Maitre, S. Boussat, D. Jean, M. Gouge, L. Brochard, B. Housset, S. Adnot, and C. Delclaux
Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury
Eur. Respir. J.,
July 1, 2001;
18(1):
100 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Meyer, A. L. Cardoni, Z. Xiang, R. D. Cornwell, and R. B. Love
Vascular Endothelial Growth Factor in Human Lung Transplantation
Chest,
January 1, 2001;
119(1):
137 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Kazi, W. S. Lee, E. Wagner, and P. M. Becker
VEGF, fetal liver kinase-1, and permeability increase during unilateral lung ischemia
Am J Physiol Lung Cell Mol Physiol,
September 1, 2000;
279(3):
L460 - L467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Boussat, S. Eddahibi, A. Coste, V. Fataccioli, M. Gouge, B. Housset, S. Adnot, and B. Maitre
Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells
Am J Physiol Lung Cell Mol Physiol,
August 1, 2000;
279(2):
L371 - L378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Barazzone and C. W. White
Mechanisms of Cell Injury and Death in Hyperoxia . Role of Cytokines and Bcl-2 Family Proteins
Am. J. Respir. Cell Mol. Biol.,
May 1, 2000;
22(5):
517 - 519.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. M. Becker, A. Alcasabas, A. Y. Yu, G. L. Semenza, and T. E. Bunton
Oxygen-Independent Upregulation of Vascular Endothelial Growth Factor and Vascular Barrier Dysfunction during Ventilated Pulmonary Ischemia in Isolated Ferret Lungs
Am. J. Respir. Cell Mol. Biol.,
March 1, 2000;
22(3):
272 - 279.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. LASSUS, A. RISTIMAKI, O. YLIKORKALA, L. VIINIKKA, and S. ANDERSSON
Vascular Endothelial Growth Factor in Human Preterm Lung
Am. J. Respir. Crit. Care Med.,
May 1, 1999;
159(5):
1429 - 1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Watkins, C. T. D'Angio, R. M. Ryan, A. Patel, and W. M. Maniscalco
Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury
Am J Physiol Lung Cell Mol Physiol,
May 1, 1999;
276(5):
L858 - L867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Klekamp, K. Jarzecka, and E. A. Perkett
Exposure to Hyperoxia Decreases the Expression of Vascular Endothelial Growth Factor and Its Receptors in Adult Rat Lungs
Am. J. Pathol.,
March 1, 1999;
154(3):
823 - 831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Acarregui, S. T. Penisten, K. L. Goss, K. Ramirez, and J. M. Snyder
Vascular Endothelial Growth Factor Gene Expression in Human Fetal Lung In Vitro
Am. J. Respir. Cell Mol. Biol.,
January 1, 1999;
20(1):
14 - 23.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. M. Maniscalco, R. H. Watkins, G. S. Pryhuber, A. Bhatt, C. Shea, and H. Huyck
Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons
Am J Physiol Lung Cell Mol Physiol,
April 1, 2002;
282(4):
L811 - L823.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 American Thoracic Society.
|
|
|